Document is current
Any future updates will be listed below
-
Authors
Toda, Yumiko
Ashizawa, Masahiro
Murahashi, Rui
Nakashima, Hirotomo
Ikeda, Takashi
Kawaguchi, Shin-ichiro
Nagayama, Takashi
Umino, Kento
Minakata, Daisuke
Morita, Kaoru
Yamamoto, Chihiro
Hatano, Kaoru
Sato, Kazuya
Fujiwara, Shin-ichiro
Ohmine, Ken
Kanda, Yoshinobu https://orcid.org/0000-0002-4866-9307
- License Information
-
More Information
Article History
Received: 16 August 2023
Revised: 29 February 2024
Accepted: 6 March 2024
First Online: 5 April 2024
Declarations
:
: YK received honoraria from Sanofi. SF received honoraria from Astellas, Chugai, Kyowa Hakko Kirin, Nippon Shinyaku, Novartis, Asahi Kasei Pharma, Sanofi, and Abbvie. The rest of the authors declare no conflict of interest.
: All the procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. This article does not contain any studies with animals performed by any of the authors. This study has been approved by the research ethics committee of Jichi medical University.
: We adopted an opt-out approach based on the ethical guidelines established by the government, because this study was observational study using only existing medical records.
